The state of Maryland currently has 17 active clinical trials seeking participants for Atopic Dermatitis research studies. These trials are conducted in various cities, including Baltimore, Bethesda, Rockville and Annapolis.
Systems Biology of Early Atopy
NCT04798079
Recruiting
The goal of this study is to establish a birth cohort that collects prenatal and early life biosamples and environmental samples and rigorously phenotypes young children for food allergy and Atopic Dermatitis (AD) to identify prenatal and early life markers of high risk for food allergy and AD, as well as biological pathways (endotypes) that result in these conditions. Primary Objectives: * To study the role and interrelationships of established and novel clinical, environmental, biological, a... Read More
Gender:
ALL
Ages:
0 years and above
Trial Updated:
05/13/2025
Locations: Johns Hopkins Children's Center, Department of Allergy & Immunology, Baltimore, Maryland
Conditions: Allergic Diseases, Food Allergy, Atopic Dermatitis
Register for Updates
A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC
NCT03661866
Recruiting
TARGET-DERM is a longitudinal, observational study of adult and pediatric patients being managed for Atopic Dermatitis and other Immune-Mediated Inflammatory Skin Conditions (IMISC) in usual clinical practice. TARGET-DERM will create a research registry of patients with IMISC within academic and community real-world practices in order to assess the safety and effectiveness of current and future therapies.
Gender:
ALL
Ages:
All
Trial Updated:
05/02/2025
Locations: DermAssociates, LCC, Rockville, Maryland
Conditions: Atopic Dermatitis, Hidradenitis Suppurativa, Vitiligo, Psoriasis, Alopecia Areata, Chronic Spontaneous Urticaria
Register for Updates
Dupilumab De-escalation in Pediatric Atopic Dermatitis
NCT06116526
Recruiting
This is a pilot investigator-blinded, randomized clinical trial to assess the feasibility of dupilumab treatment discontinuation or dose-reduction in children aged 1-17 years who have achieved sustained atopic dermatitis (AD) control on dupilumab.
Gender:
ALL
Ages:
Between 1 year and 17 years
Trial Updated:
01/13/2025
Locations: Johns Hopkins Univerisity, Baltimore, Maryland
Conditions: Atopic Dermatitis
Register for Updates
Registry for Systemic Eczema Treatments
NCT06136767
Recruiting
The Registry for Systemic Eczema Therapies (RESET) registry is a database and biospecimen repository for patients with pediatric-onset atopic dermatitis (AD) who have used or will initiate any systemic treatment(s) for AD. The goal of the registry is to enable more efficient research recruitment and data collection as well as timely notification to enrollees about newly FDA-approved treatments for AD.
Gender:
ALL
Ages:
Between 1 year and 26 years
Trial Updated:
01/13/2025
Locations: Johns Hopkins University, Baltimore, Maryland
Conditions: Atopic Dermatitis
Register for Updates
Phase 2 Trial of HY209gel in Atopic Dermatitis Patients
NCT06024499
Recruiting
This is a randomized, double-blind, placebo-controlled, multi-center, phase 2 study in patients with mild to moderate Atopic Dermatitis(AD), which consists of 2 parts.
Gender:
ALL
Ages:
Between 18 years and 100 years
Trial Updated:
04/24/2024
Locations: Continental Clinical Solutions, LLC, Towson, Maryland
Conditions: Atopic Dermatitis, Atopic Dermatitis Eczema, Atopic Dermatitis of Scalp
Register for Updates